Lapatinib as second-line treatment after the double block pertuzumab-trastuzumab: a case report

We report the case of a young, 36-year-old patient diagnosed with multifocal breast carcinoma, undergoing neoadjuvant chemotherapy, surgery and adjuvant treatment. The patient presented an early recovery of liver disease after only 7 months of free interval. Histological reevaluation after liver bi...

Full description

Bibliographic Details
Main Authors: Valentina Magri, Simone Scagnoli, Gabriele Piesco, Giulia Pomati
Format: Article
Language:English
Published: AboutScience Srl 2018-10-01
Series:AboutOpen
Subjects:
Online Access:https://journals.aboutscience.eu/index.php/aboutopen/article/view/131